胎球蛋白A对腹膜透析患者冠状动脉钙化发生起始的影响因素分析
收稿日期: 2020-08-28
网络出版日期: 2022-07-26
基金资助
上海市宝山区卫生青年医学人才培养计划(bswsyq-2015-A06);上海市宝山区科技创新专项基金(18-E-19)
晏焕青, 谢琼虹, 尚达, 戴淑琪, 朱彤莹 . 胎球蛋白A对腹膜透析患者冠状动脉钙化发生起始的影响因素分析[J]. 内科理论与实践, 2021 , 16(01) : 49 -52 . DOI: 10.16138/j.1673-6087.2021.01.011
[1] | Rogan A, McCarthy K, McGregor G, et al. Quality of life measures predict cardiovascular health and physical performance in chronic renal failure patients[J]. PLoS One, 2017, 12(9): e0183926. |
[2] | Fukao W, Hasuike Y, Yamakawa T, et al. Oral versus intravenous iron supplementation for the treatment of iron deficiency anemia in patients on maintenance hemodialysis-effect on fibroblast growth factor-23 metabolism[J]. J Ren Nutr, 2018, 28(4): 270-277. |
[3] | Wang AY. Calcium balance and negative impact of calcium load in peritoneal dialysis patients[J]. Perit Dial Int, 2014, 34(4): 345-352. |
[4] | 晏焕青, 谢琼虹, 尚达, 等. 冠脉钙化积分与腹膜透析患者预后的相关性研究[J]. 上海交通大学学报(医学版), 2017, 37(8): 1120-1126. |
[5] | Taylor AJ, Burke AP, O'Malley PG, et al. A comparison of the Framingham risk index, coronary artery calcification, and culprit plaque morphology in sudden cardiac death[J]. Circulation, 2000, 101(11): 1243-1248. |
[6] | Dabrowska AM, Tarach JS, Wojtysiak-Duma B, et al. Fetuin-A (AHSG) and its usefulness in clinical practice. Review of the literature[J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2015, 159(3): 352-359. |
[7] | Chen HY, Chiu YL, Hsu SP, et al. Relationship between fetuin A, vascular calcification and fracture risk in dialysis patients[J]. PLoS One, 2016, 11(7): e0158789. |
[8] | Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography[J]. J Am Coll Cardiol, 1990, 15(4): 827-832. |
[9] | Lu W, Ren C, Han X, et al. The protective effect of different dialysis types on residual renal function in patients with maintenance hemodialysis[J]. Medicine (Baltimore), 2018, 97(37): e12325. |
[10] | Cai MM, Wigg B, Smith ER, et al. Relative abundance of fetuin- A in peritoneal dialysis effluent and its association with in situ formation of calciprotein particles: an observational pilot study[J]. Nephrology (Carlton), 2015, 20(1): 6-10. |
[11] | 莫颖, 任荣, 张艳, 等. 血清胎球蛋白A、C反应蛋白及骨保护素水平与血液透析患者血管钙化相关性研究[J]. 临床肾脏病杂志, 2019, 19(11): 853-856. |
[12] | 张曼, 张京慧, 温小军, 等. 老年血液透析患者血清hs-CRP、Fetuin-A水平与心脏瓣膜钙化和血管钙化的关系[J]. 分子诊断与治疗杂志, 2020, 12(3): 296-299. |
[13] | Rroji M, Figurek A, Spasovski G. Should we consider the cardiovascular system while evaluating CKD-MBD[J]?. Toxins (Basel), 2020, 12(3): 140. |
[14] | 尹飞挺, 周婷婷, 周岩, 等. 腹膜透析患者心血管钙化的发生率及影响因素[J]. 肾脏病与透析肾移植杂志, 2015, 24(5): 435-440. |
[15] | 买合丽亚·卡买尔江, 黄莺. 探讨冠脉钙化积分和冠脉钙化危险因素与新疆不同民族人群冠脉钙化的相关性研究[J]. 中西医结合心血管病电子杂志, 2019, 7(21): 67-69. |
[16] | Ouwens DM, Sell H, Greulich S, et al. The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease[J]. J Cell Mol Med, 2010, 14(9): 2223-2234. |
/
〈 |
|
〉 |